HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.

@article{Clifford1999HAARTIP,
  title={HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy.},
  author={David B Clifford and Constantin T. Yiannoutsos and M Glicksman and David M. Simpson and Elyse J. Singer and Peter J. Piliero and Christina M. Marra and Gordon S. Francis and Justin C. Mcarthur and Kenneth Lyle Tyler and Alex C. Tselis and Newton E. Hyslop},
  journal={Neurology},
  year={1999},
  volume={52 3},
  pages={
          623-5
        }
}
Introduction of highly active antiretroviral therapy (HAART) has been associated with many changes in the complications of human immunodeficiency virus (HIV) infection. A cohort of 25 HIV patients with progressive multifocal leukoencephalopathy (PML) treated with HAART experienced a median survival of >46 weeks. This is an improvement in prognosis compared with recent historic experience and correlated with HIV RNA viral load reductions. We conclude that current HIV therapy is important in… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 92 CITATIONS, ESTIMATED 60% COVERAGE

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy

  • Journal of NeuroVirology
  • 2001
VIEW 14 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Progressive multifocal leukoencephalopathy.

  • Current treatment options in neurology
  • 2008
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Progressive Multifocal Leukoencephalopathy in HIV

VIEW 3 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Progressive multifocal leukoencephalopathy and natalizumab

  • Journal of Neurology
  • 2011
VIEW 5 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2000
2018

CITATION STATISTICS

  • 9 Highly Influenced Citations